Freenome is a biotechnology company that applies multi-omics and machine-learning techniques to early cancer detection. The organization currently reports a workforce of roughly 425 people. Recent staffing data shows 24 new hires and 41 departures, suggesting the team is continually adjusted to match clinical research, product development, and commercial goals. The balance of scientific, technical, and corporate roles underscores the company’s focus on translating laboratory insights into market-ready diagnostics.
Engineering is Freenome’s largest department with about 195 employees, accounting for nearly half of total headcount and highlighting the importance of data science and software development in its platform. Healthcare professionals—including clinical, research, and laboratory staff—form the second-largest group at 48 employees. Business Management (45), Marketing & Product (24), Operations (23), Finance & Administration (18), Information Technology (18), Human Resources (15), and Quality (10) round out the roster, while 29 employees are classified in other support functions. This distribution reflects a strong technical core complemented by the cross-functional expertise required to advance medical tests from concept to commercialization.
Freenome’s workforce is concentrated in California, with approximately 183 employees based in San Francisco, the primary hub for research, engineering, and corporate teams. Additional clusters are located in San Diego (14) and San Jose (13), providing access to life-science talent and laboratory space across the state. Smaller offices or remote groups operate in Boston, Seattle, Los Angeles, Austin, Denver, and New York, while about 185 employees are distributed across other locales. This geographic spread allows the company to tap into diverse biotech and technology ecosystems while supporting flexible work arrangements.